Literature DB >> 12354295

Long-term post-synaptic consequences of methamphetamine on preprotachykinin mRNA expression.

Kamisha L Johnson-Davis1, Glen R Hanson, Kristen A Keefe.   

Abstract

Exposure to repeated high doses of methamphetamine produces long-term toxicity to central monoamine systems and alters striatonigral pathway function 3 weeks after exposure. To determine whether these changes in the striatonigral pathway persist for longer we examined neuropeptide mRNA expression in the striatum and cytochrome oxidase activity in the output nuclei of the basal ganglia after treatment with multiple high doses of methamphetamine. Rats exposed to multiple high doses of methamphetamine had significant depletion in dopamine and serotonin content, decreases in tyrosine hydroxylase immunoreactivity, and decreases in preprotachykinin mRNA expression, 6 and 12 weeks after methamphetamine treatment. Preprotachykinin mRNA expression was significantly reduced by approximately 20% in the middle striatum and approximately 32% in the caudal striatum, 6 weeks after treatment. Twelve weeks after treatment, preprotachykinin mRNA expression continued to be significantly reduced by approximately 20% in the middle striatum and approximately 14% in the caudal striatum. Cytochrome oxidase histochemical staining in the entopeduncular nucleus and substantia nigra pars reticulata was not significantly different from that in controls at either time point. These data suggest that neurotoxic regimens of methamphetamine induce changes in striatonigral neurons that persist for up to 3 months, although there is some recovery.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12354295     DOI: 10.1046/j.1471-4159.2002.01095.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  9 in total

1.  Disruption of subcellular Arc/Arg 3.1 mRNA expression in striatal efferent neurons following partial monoamine loss induced by methamphetamine.

Authors:  Melissa L Barker-Haliski; Katharina Oldenburger; Kristen A Keefe
Journal:  J Neurochem       Date:  2012-10-10       Impact factor: 5.372

2.  Chronic methamphetamine exposure suppresses the striatal expression of members of multiple families of immediate early genes (IEGs) in the rat: normalization by an acute methamphetamine injection.

Authors:  Michael T McCoy; Subramaniam Jayanthi; Jacqueline A Wulu; Genevieve Beauvais; Bruce Ladenheim; Tracey A Martin; Irina N Krasnova; Amber B Hodges; Jean Lud Cadet
Journal:  Psychopharmacology (Berl)       Date:  2011-01-13       Impact factor: 4.530

3.  Changes in neural circuitry regulating response-reversal learning and Arc-mediated consolidation of learning in rats with methamphetamine-induced partial monoamine loss.

Authors:  Elissa D Pastuzyn; Kristen A Keefe
Journal:  Neuropsychopharmacology       Date:  2013-10-22       Impact factor: 7.853

4.  Widespread increases in malondialdehyde immunoreactivity in dopamine-rich and dopamine-poor regions of rat brain following multiple, high doses of methamphetamine.

Authors:  Kristen A Horner; Yamiece E Gilbert; Susan D Cline
Journal:  Front Syst Neurosci       Date:  2011-05-09

5.  Effect of methamphetamine neurotoxicity on learning-induced Arc mRNA expression in identified striatal efferent neurons.

Authors:  David P Daberkow; Matthew D Riedy; Raymond P Kesner; Kristen A Keefe
Journal:  Neurotox Res       Date:  2008-12       Impact factor: 3.911

6.  Lack of effect of kappa-opioid receptor agonism on long-term methamphetamine-induced neurotoxicity in rats.

Authors:  Kamisha L Johnson-Davis; Glen R Hanson; Kristen A Keefe
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.911

7.  Phasic-like stimulation of the medial forebrain bundle augments striatal gene expression despite methamphetamine-induced partial dopamine denervation.

Authors:  Christopher D Howard; Elissa D Pastuzyn; Melissa L Barker-Haliski; Paul A Garris; Kristen A Keefe
Journal:  J Neurochem       Date:  2013-04-01       Impact factor: 5.372

8.  Methamphetamine-induced dopaminergic deficits and refractoriness to subsequent treatment.

Authors:  Jarom E Hanson; Elisabeth Birdsall; Kristi S Seferian; Marcus A Crosby; Kristen A Keefe; James W Gibb; Glen R Hanson; Annette E Fleckenstein
Journal:  Eur J Pharmacol       Date:  2009-04-01       Impact factor: 4.432

9.  The effects of methamphetamine on core body temperature in the rat--part 2: an escalating regimen.

Authors:  Benita J Myles; Karen E Sabol
Journal:  Psychopharmacology (Berl)       Date:  2008-04-26       Impact factor: 4.530

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.